Sign inJoin waitlistJoin the waitlist

KL

Kenneth Lucas

Physician · TIDALHEALTH SPECIALTY CARE LLC

Credentials: · · · ·

History

TIDALHEALTH SPECIALTY CARE LLC
Present

Pediatrics
UPMC Children's Hospital of Pittsburgh
1989–1992
Doctor of Medicine
1985–1989

Research

Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a…
Biology of Blood and Marrow Transplantation · 2011 · 226 citations
Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell…
Blood · 1998 · First of 8 authors · 176 citations
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation
Blood · 1996 · First of 5 authors · 162 citations

Richard O’Reilly
4 papers
TS
Trudy Small
4 papers
EP
Esperanza Papadopoulos
3 papers
Kent Robertson
3 papers
MC
Melanie Comito
3 papers
AC
Alexandra Cheerva
2 papers
AB
Arthur Brown
2 papers
Biljana Horn
2 papers
Brandt Groh
2 papers
DU
David Ungar
2 papers
DS
Donna Salzman
2 papers
Franklin Smith
2 papers

Grants

Virus Specific CTL Following T Cell Depleted SCT
National Cancer Institute · R01
Contact PI · $984.5K · Pennsylvania State Univ Hershey Med Ctr
2005–2010
Immunotherapy for EBV Positive Hodgkin's Disease
National Cancer Institute · R21
Contact PI · $581.2K · Pennsylvania State Univ Hershey Med Ctr
2001–2005
Adoptive Immunotherapy for Posttransplant Ebv Lymphoma
National Cancer Institute · R01
Contact PI · $720K · University of Alabama at Birmingham
1997–2003
Immunotherapy with Cmv and Ebv Specific t Lymphocytes
National Cancer Institute · R21
Contact PI · $282.5K · University of Alabama at Birmingham
1999–2002

Clinical trials

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs
Principal investigator · Terminated · Phase 1, Phase 2
University of Louisville
2015–2016
Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation
Principal investigator · Withdrawn · Phase 1
University of Louisville
2015
Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
Principal investigator · Completed · Phase 1
University of Louisville
2013–2016
A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma
Principal investigator · Withdrawn · Phase 1
University of Louisville
2013–2016